Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 21,017 shares at $174.65 ($3.5M) on 2020-05-18, disclosed to the SEC on 2020-05-19.
Open-market sale of $3.5M CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $168.00 | 10,519 | $1.8M | 49.9% |
| 2 | $168.81 | 4,899 | $827K | 23.3% |
| 3 | $168.81 | 4,899 | $827K | 23.3% |
| 4 | $174.65 | 350 | $61K | 1.7% |
| 5 | $174.65 | 350 | $61K | 1.7% |
| Total | $168.60 avg | 21,017 |
| $3.5M |
| 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |